Global Longlife Hospital and Research IPO listing price is ₹ 135.35, issue price is ₹ 140.00, and currently trading at ₹ 27.10 as on June 12, 2025. Global Longlife Hospital and Research IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Global Longlife Hospital and Research IPO is a Fixed Price listing on BSE SME exchange. The company is based in Ahmedabad and caters to Healthcare - Hospitals And Clinic sector. Interactive Financial Services is the merchant banker of Global Longlife Hospital and Research IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 2nd March 2022.
Global Longlife Hospital and Research IPO offer price is ₹ 140.00 and got listed at ₹ 135.35. Read Global Longlife Hospital and Research IPO details mentioned above.The IPO of Global Longlife Hospital and Research Limited was listed on 4th May 2022. As of today, Global Longlife Hospital and Research IPO is trading at ₹ 27.10, compared to the previous day’s close of ₹ 27.10. Read the report above for detailed IPO performance.
The issue price of Global Longlife Hospital and Research IPO was ₹ 140.00 per equity share.
Global Longlife Hospital and Research IPO was listed at ₹135.35 on the stock exchange on 4th May 2022. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of June 12, 2025, the current market price of Global Longlife Hospital and Research IPO is ₹ 27.10.
The 52-week high for Global Longlife Hospital and Research IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Global Longlife Hospital and Research IPO listed at ₹ 135.35 against the issue price of ₹ 140.00 per equity share, showing a listing day gain/loss of -4.65 (-3.32%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Global Longlife Hospital and Research IPO stock moved from its listing price of ₹ 135.35 to the current price of ₹27.10 per equity share, reflecting a change of -79.98% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Global Longlife Hospital and Research IPO issue date of 4th May 2022 and CMP of ₹27.10, the estimated CAGR is approximately -40.92%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Global Longlife Hospital and Research IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Global Longlife Hospital and Research Financial Review Page
Merchant Banker(s) of Global Longlife Hospital and Research IPO: Interactive Financial Services Limited
Global Longlife Hospital and Research IPO subscription was 1.50 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Global Longlife Hospital and Research IPO listed at a listing price of 135.35 against the offer price of 140.00.
The current market price of Global Longlife Hospital and Research is 27.10.
Why Us?